Aug 2026· GSC Advanced Research and Reviews· 0 citations
TL;DR
Male sex was a statistically significant independent predictor of heart disease after controlling for other clinical variables and the findings support sex-specific screening and preventive strategies for high-cholesterol male patients and demonstrate the value of interpretable machine learning models for clinical decision support.
Abstract
Cardiovascular disease remains a major cause of mortality and economic burden in the United States. This study developed and evaluated supervised machine learning models to predict heart disease risk from routine clinical variables and tested whether male patients with high cholesterol have higher odds of heart disease than female patients. Using a publicly available clinical dataset of 918 patients, the Cross-Industry Standard Process for Data Mining (CRISP-DM) framework guided exploratory analysis, data cleaning, median imputation of irregular cholesterol values, and feature selection using principal component analysis (PCA) and SelectKBest. Logistic Regression, Support Vector Machine (SVM), and a soft voting ensemble were trained and tuned using grid search with stratified 5-fold cross-validation. The ensemble achieved the highest predictive performance (accuracy = 0.940, F1 = 0.950, receiver operating characteristic area under the curve [ROC-AUC] = 0.958). Logistic Regression achieved comparable performance (accuracy = 0.929, F1 = 0.940, ROC-AUC = 0.958) and was selected for hypothesis testing because of its interpretability. Among patients with cholesterol ≥240 mg/dL, male sex was a statistically significant independent predictor of heart disease after controlling for other clinical variables. The findings support sex-specific screening and preventive strategies for high-cholesterol male patients and demonstrate the value of interpretable machine learning models for clinical decision support. Larger externally validated datasets are needed to assess generalizability.
The results confirm the effectiveness of ensemble learning approaches for medical diagnostics and highlight the potential of implementing ML-based screening tools in the limited resource healthcare environment in Pakistan.
Awais Khursheed, Soban Ahmed, Sibghat Ullah et al.· International Journal of Inn...· 0 citations
It is demonstrated that machine learning models can effectively identify high-risk patients and that minority data resampling significantly improves mortality classification reliability, and the approach offers potential value for clinical decision support systems and prioritised care pathways.
Abiodun Ojo· Journal International Review...· 0 citations
The findings suggest that Logistic Regression is more suitable as a decision-support model for early heart disease screening due to its higher sensitivity, accuracy, and specificity.
Yan Risa, Aspi Sururi, M. Asadullah et al.· International Journal for Sc...· 0 citations
Findings highlight blood pressure and body size measures as the dominant clinical signals in this dataset, while demonstrating the potential of an explainable machine-learning model based on routinely collected clinical data to support cardiovascular risk stratification and clinical decision-making in hypertensive pati...
C. M. Anyanwu, J. C. Onyianta, Ogechi Gift Onyedi et al.· Nature Journal of Emerging S...· 0 citations
Evaluated machine learning algorithms for predicting diabetes risk from routinely available clinical and lifestyle variables confirm that ensemble tree-based methods, particularly Random Forest, provide a reliable, interpretable, and deployable basis for diabetes risk screening, especially in resource-constrained setti...
T. Olayinka· FUDMA Journal of Sciences· 0 citations
Development and validate an interpretable machine learning model to predict the 1- to 3-year risk of cardiovascular events in breast cancer patients by integrating baseline and treatment variables and identified endocrine therapy, anemia management therapy, and history of cerebrovascular disease as the top three predic...
Lu-Xin Wang, Rui Yan, Xin-Yu Zhu et al.· Frontiers in Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.